According to Jon Bigelow, Executive Director of the Coalition for Healthcare Communication, the beginning of the Biden administration has had a largely positive impact on the biopharma industry, notably marked by an effort to “stick to the science”; a fairly efficient roll-out of COVID-19 vaccines that allows reopening of schools and many aspects of normal daily life; and expansion of Affordable Care Act (ACA) coverage. But behind the scenes, pressure continues to build surrounding high prescription drug costs and changes in tax policy.

It is scientifically proven that teenagers are clumsy. The main reason teens are so awkward is that they are growing fast – for example, a 13-year-old’s legs can grow one centimeter a month! The brain must continuously recalibrate precise calculations about movements, and when it misfires, teens stumble. Similarly, COVID-19 caused a sudden growth spurt for Artificial Intelligence (AI) technology in commercial life sciences. And like the newfound height and strength of a growing teenager, AI may feel all “arms and legs” for organizations anxious to leverage its great promises in a post-pandemic, digital-first world.

Johnson & Johnson said on June 10 the U.S. Food and Drug Administration extended the shelf life of the company’s single-shot Covid-19 vaccine from three months to four-and-a-half months, as millions of unused doses nationwide near expiration.

The Biden administration plans to donate 500 million Pfizer coronavirus vaccine doses to nearly 100 countries over the next two years, three sources familiar with the matter told Reuters on June 9.

UK researchers led by a group at Newcastle University identified a gene, HLA-DRB1*04:01, which was three times more common in asymptomatic Covid-19 patients than in people with symptomatic disease. The research was published in the journal HLA.

The U.S. Centers for Disease Control and Prevention (CDC) eased travel recommendations for more than 110 countries and territories, including Japan just ahead of the Olympics.

A report on the origins of Covid-19 by a U.S. government national laboratory concluded that the hypothesis of a virus leak from a Chinese lab in Wuhan is plausible and deserves further investigation, the Wall Street Journal said on June 7, citing people familiar with the classified document.

An experimental new type of antibody drug from IGM Bioscience Inc. may be more potent at inhibiting the coronavirus and its variants than antibody therapies currently in use, research in mice suggests. Vaping has been linked with higher rates of Covid-19 in some studies.

Safety concerns about Johnson & Johnson’s Covid-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting unused.

The United States had administered 301,638,578 doses of Covid-19 vaccines in the country and distributed 371,520,735 doses as of the morning of June 6, the U.S. Centers for Disease Control and Prevention said.